Alan Crane
InvestorEntrepreneur Partner at Polaris Partners
FoundedDare BioscienceDyno TherapeuticsKSQ TherapeuticsNavitor PharmaceuticalsPandion TherapeuticsPandion Therapeutics Holdco
About
Alan Crane joined Polaris Partners in 2002 as an entrepreneur partner, focusing on building and investing in healthcare companies. He has held founder, CEO, and Chairman roles across ten Polaris companies, including co-founding Zag Bio, Seismic Therapeutic, and Dyno Therapeutics, and founding Pandion Therapeutics (acquired by Merck). He was previously president and CEO of Momenta Pharmaceuticals (acquired by J&J) and SVP of corporate development at Millennium Pharmaceuticals, and holds degrees from Harvard College, Harvard Graduate School of Arts & Sciences, and Harvard Business School.
Invests in
BiotechDigital HealthHealthtech
Deals · 8
Seismic TherapeuticBoard seat
via Polaris Partners · filed Sep 2024 · $146.3M raise
Pandion Therapeutics HoldcoBoard seat
via Polaris Partners · filed Apr 2020 · $80M raise
Navitor PharmaceuticalsBoard seat
via Polaris Partners · filed Mar 2018 · $25M raise
Pandion TherapeuticsBoard seat
via Polaris Partners · filed Jan 2018 · $57.6M raise
Seventh Sense BiosystemsBoard seat
via Polaris Partners · filed Sep 2017 · $10M raise
VaccinexBoard seat
via Polaris Partners · filed Jul 2017 · $18.2M raise
Dare BioscienceBoard seat
via Polaris Partners · filed Oct 2016 · $1 raise
XTuit PharmaceuticalsBoard seat
via Polaris Partners · filed Sep 2016 · $22M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Polaris Partners
Network9
Investors connected to Alan in public investor directories — a warm-intro map.